Cargando…
Tenofovir rescue therapy in chronic hepatitis B patients who failed previous nucleoside analogue treatment
BACKGROUND: Tenofovir (TDF) is considered as the first line therapy for chronic hepatitis B. This study presents the results of TDF monotherapy in patients who failed previous nucleoside analogue treatment. METHODS: The study included 29 patients treated with TDF 245 mg once daily for 18 months afte...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778152/ https://www.ncbi.nlm.nih.gov/pubmed/26612013 http://dx.doi.org/10.1007/s12072-015-9681-6 |